Author name: Prashant Reddy

T. Prashant Reddy graduated from the National Law School of India University, Bangalore, with a B.A.LLB (Hons.) degree in 2008. He later graduated with a LLM degree (Law, Science & Technology) from the Stanford Law School in 2013. Prashant has worked with law firms in Delhi and in academia in India and Singapore. He is also co-author of the book Create, Copy, Disrupt: India's Intellectual Property Dilemmas (OUP).

Bombay High Court paves the way for the release of ‘Chashme Budoor’

/ By / Copyright

In a brief, well-reasoned order dated 4th April, 2013, Justice S. J. Kathawalla of the Bombay High Court refused to grant renowned playwright, director and script-writer Sai Paranjape, an interim injunction restraining the release of the movie ‘Chashme Budoor’ today. The judgment can be accessed over here.  The movie which is being released today is a remake of a movie by the same name which was released in 1981. This older version was written and directed by the Plaintiff who had […]

Bombay High Court paves the way for the release of ‘Chashme Budoor’ Read More »

Supreme Court rejects bid by Novartis to patent Glivec

/ By / Patent

In a 112 page judgment delivered earlier this morning, a Bench of the Supreme Court, comprising of Mr. Justice Aftab Alam and Ms. Justice Ranjana Prakash Desai have upheld the rejection of the patent application (1602/MAS/1998) filed by Novartis for Glivec in 1998 before the Indian Patent Office. The judgment can be accessed over here. If not, please download the judgment from here. The patent application had initially been rejected by the Controller of Patents in 2006, after hearing 5

Supreme Court rejects bid by Novartis to patent Glivec Read More »

Public health activists lose challenge against Gilead before the Competition Commission of India

/ By / Competition Law

The Competition Commission of India (CCI), in an order dated March 5, 2013 has dismissed, at the threshold stage, a complaint filed by a public health (HIV) activist against Gilead Inc. alleging that the company was engaged in anti-competitive activities with respect to licensing of its technologies relating to anti-HIV drugs. The activist was represented by Advocates Ms. Savita Singh, Ms. Veena Johari and Ms. Kajal Bhardwaj. The order can be accessed over here.  Complaints before the CCI usually go

Public health activists lose challenge against Gilead before the Competition Commission of India Read More »

Guest Post: U.S. Supreme Court hears arguments in reverse payments case

/ By / Competition Law

The U.S. Supreme Court recently heard arguments on the legality of reverse payment settlements in the pharmaceutical sector, where a patent holder would pay a generic pharmaceutical manufacturer to delay or withdraw any challenges to patent validity. Given the increasing number of reverse payment settlements, the final holding of the U.S. Supreme Court is going to have a significant impact on competition in the pharmaceutical industry.  We have for our readers a guest post on this topic and the hearing

Guest Post: U.S. Supreme Court hears arguments in reverse payments case Read More »

Patent Office publishes final version of Guidelines for Examination of Biotechnology Applications for Patents

/ By / Uncategorized

Image from here. The Patent Office has published the final version of the “Guidelines for Examination of Biotechnology Applications for Patents”, accessible over here, dated March 25, 2013. The draft version of these guidelines was published initially in December, 2012 and made available for public comment on the Patent Office website. The public comments received by the Patent Office, most of which were negative, were published on the patent office website and I’m told that the Patent Office did organize

Patent Office publishes final version of Guidelines for Examination of Biotechnology Applications for Patents Read More »

Copyright Rules, 2013 designed to fail the Copyright Board

/ By / Copyright

While the Copyright Office has made a few amendments, to the draft version of the Copyright Rules, 2012 governing the Copyright Board, the amendments in the final notified version fail to go far enough. (Our previous post can be accessed over here)                                           Let’s start with the good news first.  Good-news: The Copyright Office has inserted a new sub-rule (d)

Copyright Rules, 2013 designed to fail the Copyright Board Read More »

A clarification on the Fox-‘Knockout’ copyright dispute

/ By / Copyright

In this post, we would like to clarify one of our earlier posts that we had published on Monday regarding the Fox-‘Knockout’ copyright dispute. In the earlier post we had reported, on the basis of a NDTV/Mid-Day report that Fox had won a copyright infringement claim against the Indian producers of the movie ‘Knockout’ for allegedly infringing Fox’s copyright in the script for the movie ‘Phone-Booth’. The report had also mentioned that Fox was awarded Rs. 1.25 crore in damages. 

A clarification on the Fox-‘Knockout’ copyright dispute Read More »

Pratibha Syntex lawsuit still pending before the Delhi High Court: Did Microsoft mislead the Californian Attorney General?

/ By / Copyright

For a brief background to this post, I point readers to two of my previous posts available over here and here, where I discussed an unfair competition lawsuit brought against an exporting Indian textile manufacturer, Pratibha Syntex, by the State of California on the grounds that it was using pirated software, thus giving it a competitive edge over Californian manufacturers who used legitimate computer software.  As I had mentioned earlier, the complaint filed by the Californian Attorney General was delightfully

Pratibha Syntex lawsuit still pending before the Delhi High Court: Did Microsoft mislead the Californian Attorney General? Read More »

SpicyIP Tidbit: An IP Thriller from an IP lawyer

/ By / Uncategorized

In an exciting first for the community of intellectual property lawyers in India, Dr. Kalyan Kankanala has penned a thriller novel based, with intellectual property law in India as its central theme. We haven’t seen too many legal thrillers in the Indian market. The only author that I’m aware of in this genre of writing, is Aditya Sudarshan, an incredibly talented lawyer turned author whose first book was ‘A nice quiet holiday’. In the west however not only have we

SpicyIP Tidbit: An IP Thriller from an IP lawyer Read More »

Guest Post: Kallam Anji Reddy: 1941 – 2013

/ By / Uncategorized

Dr. Anji Reddy, Image from here As many of you may have read in the newspapers, Dr. Anji Reddy, the founder of Dr. Reddy’s Laboratories Ltd., one of India’s largest pharmaceutical companies is no more. He passed away on March 15, 2013 at 3:45 PM after a battle with liver cancer. As one of the biggest names in India’s pharmaceutical industry, Dr. Reddy had a significant influence on India’s patent policy and unlike most other generics, he invested substantially in

Guest Post: Kallam Anji Reddy: 1941 – 2013 Read More »

Scroll to Top